March 07, 2025

New Clinical Guideline for Benzodiazepine Tapering Released

The new clinical practice guideline, developed in tandem by representatives from 10 medical societies, provides evidence-based and consensus recommendations for safe benzodiazepine tapering when risks outweigh benefits.

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

March 05, 2025

Researchers Find Neural Evidence of Smartphone Cue Reactivity

Craving-related neural processes were triggered by 72 hours of use restriction among a small group of 25 young adult smartphone users.

Conexiant

March 05, 2025

AAN: Ideal Dosing of Folic Acid During Pregnancy

Folic acid taken during the first trimester led to improved verbal skills and behavior in children at age 6, with no evidence of negative effects, according to new research to be presented at the American Academy of Neurology's 77th Annual Meeting.

Conexiant

March 03, 2025

More States Fast Track Foreign-Trained Physicians

Since 2023, nine states have waived U.S. residency requirements for some foreign-trained physicians, with more states considering similar changes.

KFF Health News

February 26, 2025

New Medical Malpractice Rules Issued by American Law Institute

The American Law Institute's first restatement of medical malpractice law shifts focus from customary practice to evidence-based medicine.

Conexiant

February 24, 2025

Do Black Female Doctors Die Earlier?

New JAMA Internal Medicine study finds Black female physicians face higher mortality rates than White women in general population.

Conexiant

February 21, 2025

Examining Coprescription Trends Driving the Twin Epidemic

In a 10-year U.S. cohort study, researchers identified a strong association between stimulant coprescriptions and escalating opioid doses.

Conexiant

February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant